Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RITUXIMAB-PVVR vs ROMIDEPSIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RITUXIMAB-PVVR vs ROMIDEPSIN: Safety Overview

Metric RITUXIMAB-PVVR ROMIDEPSIN
Total FAERS Reports 4,210 1,282
Deaths Reported 415 343
Death Rate 9.9% 26.8%
Hospitalizations 966 458
Average Patient Age 60.4 yrs 64.7 yrs
% Female Patients 67.9% 46.5%
FDA Approval Date N/A Mar 13, 2020
Manufacturer N/A Fresenius Kabi USA, LLC
Marketing Status Prescription Prescription